16 results
PRE 14A
PRLD
Prelude Therapeutics Inc
18 Apr 23
Preliminary proxy
4:00pm
objective responses to PRT2527, IND studies of PRT3645 and PRT3789, ensuring company-wide compliance and alignment with our budget and
culture objectives
8-K
EX-99.1
psxoox4bx3egv5af21
12 Aug 21
Prelude Therapeutics Announces Second Quarter 2021 Financial Results and Operations Update
10:41am
10-K
bkz2rdg7p7j4biq5e
16 Mar 21
Annual report
8:20am
424B4
fzibiv73l
7 Jan 21
Prospectus supplement with pricing info
4:11pm
DRS
fbl0 rxq86tu
21 Dec 20
Draft registration statement
12:00am
424B4
pb7ez7naiamwy8t9h6bi
25 Sep 20
Prospectus supplement with pricing info
4:08pm
S-1
wxybg ofr386
4 Sep 20
IPO registration
4:48pm
DRS/A
gmj5w60cw 8v
26 Aug 20
Draft registration statement (amended)
12:00am
DRS
1kak 7e4xyw
23 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next